Flynn James E 13D and 13G filings for Singular Genomics Systems, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 5:31 pm Sale |
2023-12-31 | 13G | Singular Genomics Systems, Inc. OMIC |
Flynn James E | 250,496 6.830% |
-13,393 (-5.08%) |
Filing |
| 2023-08-14 5:07 pm Sale |
2023-08-09 | 13G | Singular Genomics Systems, Inc. OMIC |
Flynn James E | 263,889 7.400% |
-35,474 (-11.85%) |
Filing |
| 2023-02-10 2:29 pm Sale |
2022-12-31 | 13G | Singular Genomics Systems, Inc. OMIC |
Flynn James E | 299,362 9.070% |
-5,372 (-1.76%) |
Filing |
| 2021-06-03 4:49 pm Purchase |
2021-06-01 | 13G | Singular Genomics Systems, Inc. OMIC |
Flynn James E | 304,734 12.890% |
304,734 (New Position) |
Filing |